These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7992547)

  • 1. [Thymosin alpha-1 and hybrid proteins consisting of tumor necrosis factor-alpha and thymosin alpha-1 enhance the efficacy of vaccination against the causative agent of plague].
    Shmelev VA; Grigor'ev BV; Mozharova TI; Popov SG
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (4):85-9. PubMed ID: 7992547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of cytokines on the immunogenic properties of hepatitis A vaccine].
    Avdeeva ZhI; Akol'zina SE; Alpatova NA; Medunitsyn NV
    Vopr Virusol; 2005; 50(2):23-7. PubMed ID: 15881393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.
    Honko AN; Sriranganathan N; Lees CJ; Mizel SB
    Infect Immun; 2006 Feb; 74(2):1113-20. PubMed ID: 16428759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection.
    Parent MA; Wilhelm LB; Kummer LW; Szaba FM; Mullarky IK; Smiley ST
    Infect Immun; 2006 Jun; 74(6):3381-6. PubMed ID: 16714568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague.
    Zvi A; Rotem S; Zauberman A; Elia U; Aftalion M; Bar-Haim E; Mamroud E; Cohen O
    Vaccine; 2017 Oct; 35(44):5995-6006. PubMed ID: 28606812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated protection against pulmonary Yersinia pestis infection.
    Parent MA; Berggren KN; Kummer LW; Wilhelm LB; Szaba FM; Mullarky IK; Smiley ST
    Infect Immun; 2005 Nov; 73(11):7304-10. PubMed ID: 16239527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli expressed flagellin C (FliC) of Salmonella Typhi improved the protective efficacy of YopE against plague infection.
    Verma SK; Gupta A; Batra L; Tuteja U
    Vaccine; 2019 Jan; 37(1):19-24. PubMed ID: 30497835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
    Philipovskiy AV; Smiley ST
    Infect Immun; 2007 Feb; 75(2):878-85. PubMed ID: 17118978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The evaluation of the efficacy of immunization against plague by the modulation in the index of the macrophagal transformation of of the peripheral blood monocytes].
    Verkina LM; Vasil'eva GI; Kiseleva AK; Moskalenko VI
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (5):53-5. PubMed ID: 9082730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies and cytokines independently protect against pneumonic plague.
    Kummer LW; Szaba FM; Parent MA; Adamovicz JJ; Hill J; Johnson LL; Smiley ST
    Vaccine; 2008 Dec; 26(52):6901-7. PubMed ID: 18926869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immune response to epitopic MAP (multiple antigen peptide) construct of LcrV antigen of Yersinia pestis in murine model.
    Shreewastav RK; Ali R; Uppada JB; Rao DN
    Cell Immunol; 2012; 278(1-2):55-62. PubMed ID: 23121976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunobiologic characteristics of hybrid proteins consisting of tumor necrosis factor alpha and thymosin alpha 1].
    Shmelev VA; Khromykh LM; Dudich EI; Sheviakova LIa; Gorbatova EA; Galaktionov VG
    Vestn Ross Akad Med Nauk; 1994; (6):55-61. PubMed ID: 7522706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of a fully recombinant plague vaccine in the guinea pig.
    Jones SM; Griffin KF; Hodgson I; Williamson ED
    Vaccine; 2003 Sep; 21(25-26):3912-8. PubMed ID: 12922126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunogenicity of B-antigen in experimental plague and pseudotuberculosis].
    Byvalov AA; Krupin VV; Gavrilov KE
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (3):49-53. PubMed ID: 16830590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model.
    Gregg KA; Harberts E; Gardner FM; Pelletier MR; Cayatte C; Yu L; McCarthy MP; Marshall JD; Ernst RK
    Vaccine; 2018 Jun; 36(28):4023-4031. PubMed ID: 29861179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270.
    Qi Z; Zhou L; Zhang Q; Ren L; Dai R; Wu B; Wang T; Zhu Z; Yang Y; Cui B; Wang Z; Wang H; Qiu Y; Guo Z; Yang R; Wang X
    Vaccine; 2010 Feb; 28(6):1655-60. PubMed ID: 20079562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of immunization protection efficacy of plague subunit vaccine].
    Zhang QW; Qi ZZ; Xin YQ; Yang YH; Wu HL; Yang HQ; Feng JP; Jin X; Cui BZ; Wang T; Wu BC; Qiu YF; Wang W; Guo ZB; Wang ZY; Yang RF; Wang H; Wang XY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Sep; 43(9):785-8. PubMed ID: 20137561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.